Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report)’s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $2.40 and traded as low as $2.18. Creative Medical Technology shares last traded at $2.27, with a volume of 8,355 shares changing hands.
Creative Medical Technology Stock Performance
The company has a 50 day moving average price of $2.40 and a two-hundred day moving average price of $3.11.
About Creative Medical Technology
Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.
Recommended Stories
- Five stocks we like better than Creative Medical Technology
- What is the Dow Jones Industrial Average (DJIA)?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Expert Stock Trading Psychology Tips
- Oilfield Leader SLB: An AI Name You Need to Know
- High Flyers: 3 Natural Gas Stocks for March 2022
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
